Zurueck zur Suche

Reporte zur Charge U039907

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

11Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
1Bleibende Schaeden
MI 2 TX 2 MS 1 PR 1 ID 1 CT 1 NJ 1 WA 1 MD 1

VAERS 2591485

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u039907

schwer
Staat
MS
Alter
18,0
Geschlecht
M
Eingang
04.03.2023
Impfdatum
04.03.2023
Beginn
04.03.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dyskinesia Syncope

Symptomtext

patient fainted about 2 minutes after vaccine was given and then once on floor jerked a little bit - once he came around, we gave him pepsi and cookies and stayed with him until he felt better . I am glad his father was with him and anticipated the response since no indication was made that he was prone to respond this way to vaccines

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
none listed
Andere Medikamente
unknown
Allergien
none
Vorherige Impfungen
-

VAERS 2530069

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U039907

mild
Staat
PR
Alter
1,0
Geschlecht
M
Eingang
13.12.2022
Impfdatum
13.12.2022
Beginn
13.12.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Rash

Symptomtext

30 min aproximately of the immunization visit, mom brings child because of a sudden rash in whole body

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NONE ACCORDING TO DAD
Vorgeschichte
NONE ACCORDING TO DAD
Andere Medikamente
NONE
Allergien
NONE ACCORDING TO DAD
Vorherige Impfungen
-

VAERS 2680016

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U039907

gering
Staat
TX
Alter
11,0
Geschlecht
U
Eingang
14.09.2023
Impfdatum
06.09.2023
Beginn
06.09.2023
Tage bis Beginn
0,0
Dosis
4
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event Unevaluable event

Symptomtext

No additional AE; a patient who was administered a fourth dose of MMR-II; This spontaneous report was received from an unspecified source on behalf of the patient referring to an 11-year-old patient of unspecified gender. The patient's concurrent conditions, medical history, previous drug reactions, drug allergies and concomitant therapies were not reported. On 06-SEP-2023, the patient was vaccinated with a fourth dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (extra dose administered) 0.5 ml/dose, lot # U039907, expiration date reported as 16-DEC-2023, and confirmed upon internal validation; administered as prophylaxis (strength, and route of administration were not provided). No symptoms reported. No additional adverse event (AE), nor product quality complaint was involved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2680016

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u039907

gering
Staat
TX
Alter
11,0
Geschlecht
U
Eingang
14.09.2023
Impfdatum
06.09.2023
Beginn
06.09.2023
Tage bis Beginn
0,0
Dosis
4
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event Unevaluable event

Symptomtext

No additional AE; a patient who was administered a fourth dose of MMR-II; This spontaneous report was received from an unspecified source on behalf of the patient referring to an 11-year-old patient of unspecified gender. The patient's concurrent conditions, medical history, previous drug reactions, drug allergies and concomitant therapies were not reported. On 06-SEP-2023, the patient was vaccinated with a fourth dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (extra dose administered) 0.5 ml/dose, lot # U039907, expiration date reported as 16-DEC-2023, and confirmed upon internal validation; administered as prophylaxis (strength, and route of administration were not provided). No symptoms reported. No additional adverse event (AE), nor product quality complaint was involved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2680552

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U039907

gering
Staat
ID
Alter
-
Geschlecht
U
Eingang
08.09.2023
Impfdatum
-
Beginn
29.08.2023
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE; patient was inadvertently given a dose of MMR II after it suffered a TE; This spontaneous report was received from an officer manager referring to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not provided. Concomitant therapies were not reported. On an unknown date, the patient was inadvertently vaccinated with a dose of with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, at a dose of 0.5 milliliters/ series (lot #U039907 with an expiration date on 16-DEC-2023), administered for prophylaxis (strength, and route of administration were not provided) after it suffered temperature excursion. The dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was exposed to a temperature excursion of 50 degrees Fahrenheit (?F) during a time frame of 0 hours, 36 minutes, 0 seconds. No additional adverse events were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2309USA001807: US-009507513-2309USA001850:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2674912

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U039907

gering
Staat
CT
Alter
1,0
Geschlecht
M
Eingang
22.08.2023
Impfdatum
17.08.2023
Beginn
18.08.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cough Rhinorrhoea

Symptomtext

On 8/22/2023, Mother called clinic due to concern for patient experiencing possible side effects from vaccination. Patient received vaccines on 8-17-2023 (first doses of MMR, Varicella, and hepatitis A). Mother reported that patient has been having runny nose, intermittent cough since patient got the vaccines. No fever. Mother said that the cough is getting worse and that "it's getting down to his chest with nasal dripping" and patient is unable to sleep at night. Mother also reported that she gave patient 3.76 mL of Tylenol orally (based on weight) every 4 hours because Mother thinks that patient is also teething. No complaints of localized injection reactions. RN advise mother of patient to bring patient to the nearest urgent care for further care and evaluation due to cough "getting worse". Mother unable to detect if child is wheezing or not during the call. Education imparted to Mother of patient, and she verbalized understanding and agreed to bring child to the nearest urgent care.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cough
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
No active medications at the time of vaccination
Allergien
No Known Allergies No Known Medication Allergies
Vorherige Impfungen
-

VAERS 2657991

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U039907

gering
Staat
NJ
Alter
1,0
Geschlecht
F
Eingang
18.07.2023
Impfdatum
19.01.2023
Beginn
19.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein
Aspartate aminotransferase increased Ataxia Blood lead normal Full blood count abnormal Gliosis Magnetic resonance imaging head abnormal Metabolic function test abnormal Neutrophil count decreased

Symptomtext

Developed ataxia on 01/22/2023

Weitere VAERSDATA-Felder
Praegender Schweregrund
Aspartate aminotransferase increased
Hospital-Tage
-
Labordaten
Brain MRI (3/27/23):small region of gliosiswithin the left parietal white matterof uncertain uncertainty CMP( 1/31/23) mildly elevatedAST (36) lead level (1/31/23) <1 cbc (1/31/23) normal exceptslightly low neutrophils
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
vitamin D drops
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 2612464

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u039907

gering
Staat
MI
Alter
4,0
Geschlecht
M
Eingang
10.04.2023
Impfdatum
05.04.2023
Beginn
05.04.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Unevaluable event

Symptomtext

n/a

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
n/a
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2543823

GLAXOSMITHKLINE BIOLOGICALS · MEASLES + MUMPS + RUBELLA (PRIORIX) · Charge U039907

gering
Staat
WA
Alter
13,0
Geschlecht
F
Eingang
27.12.2022
Impfdatum
27.12.2022
Beginn
27.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Wrong product administered

Symptomtext

Pt received MMR unintentionally.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2520039

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u039907

gering
Staat
MI
Alter
14,0
Geschlecht
M
Eingang
30.11.2022
Impfdatum
24.10.2022
Beginn
24.10.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

MenACWY was given too early.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none reported
Vorgeschichte
none reported
Andere Medikamente
none reported
Allergien
none reported
Vorherige Impfungen
-

VAERS 2514630

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U039907

gering
Staat
MD
Alter
5,0
Geschlecht
F
Eingang
23.11.2022
Impfdatum
09.11.2022
Beginn
09.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event

Symptomtext

No additional AE reported; MMR II got administered to a patient via Intramuscular route instead of Subcutaneous route; This spontaneous report has been received from a medical assistant, referring to a 5-year-old female patient. Information of concurrent condition, medical history, concomitant medication and drug reactions/allergies was not reported. On 09-NOV-2022, the patient was administered with measles, mumps, and rubella (wistar RA 27-3) virus vaccine, live (M-M-R II) 0.5 milliliter (mL) subcutaneous injection (0.5 mL, lot# U039907, expiration date 16-DEC-2023, therapy type: rHA, frequency and anatomical location were unknown) for prophylaxis via intramuscular route instead of subcutaneous route (Incorrect route of product administration). No additional adverse event (AE) was reported (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-